Compound nutrition formula with sleep disorder relieving effect

Through the combination of ingredients such as sour cherries, jujube seeds, apigenin, etc. in the compound nutrition formula, combined with vitamins and minerals, the side effects and cost problems of sleep disorder treatment in the existing technology are solved, and the rapid, effective and safe sleep improvement effect is achieved.

CN118947898APending Publication Date: 2024-11-15浙南放射医学与核技术应用研究院
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411255873.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-06
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The prior art drug treatments in relieving sleep disorders are not ideal and have side effects, psychotherapy is expensive and difficult to accept, and there is a lack of an effective solution with low cost, no or small side effects.

Method used

Provides a complex nutritional formula, including sour cherry, jujube kernel, apigenin, lily, vitamin C, vitamin D, vitamin B6, vitamin B12, magnesium and zinc, as auxiliary therapeutic foods, synergistically promote sleep.

Benefits of technology

The formula takes effect quickly, improves sleep disorders with significant effect, is easy to obtain, is safe and has no side effects, and is suitable for insomnia and high-risk groups. It is used as an auxiliary treatment food to effectively prevent and improve sleep problems.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118947898A_ABST
    Figure CN118947898A_ABST
Patent Text Reader

Abstract

The invention discloses a compound nutrition formula with an effect of relieving sleep disorders. The compound nutrition formula comprises the following components: 500 parts of sour cherries; 100 parts of semen ziziphi spinosae; 50 parts of apigenin; and 60 parts of lily. The scheme does not generate side effects or has very small side effects, and can be accepted by patients more easily in psychology and cost.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a nutritional formula, in particular to a composite nutritional formula capable of alleviating sleep disorders. Background Art

[0002] Sleep disorder is the most common mental symptom today, and its incidence rate is increasing year by year. Long-term insomnia can have a series of effects on the body, causing memory loss, depression, difficulty concentrating, etc., and irreversible damage to the central nervous system, which has become a serious public health problem. At present, there are drug intervention, social and psychological therapy, and dietary nutrition adjustment to relieve insomnia. Among them, the effect of drug treatment is not ideal and further causes different degrees of psychological burden and side effects on the subject. Psychological therapy is not cooperative enough and the cost is high.

[0003] Therefore, to address the problem of sleep disorders, there is a need to provide a solution that is acceptable to patients in terms of cost and psychological burden, and has few or no side effects. Summary of the invention

[0004] In view of the shortcomings of the prior art, the purpose of the present invention is to provide a composite nutritional formula that can alleviate sleep disorders, has no side effects or has very small side effects, and can be more easily accepted by patients in terms of psychology and cost.

[0005] To achieve the above object, the present invention provides the following technical solution: a composite nutritional formula having the effect of alleviating sleep disorders, comprising the following components:

[0006] Sour Cherry 500;

[0007] 100 parts of Chinese date seeds;

[0008] Apigenin 50 parts;

[0009] 60 servings of lily.

[0010] As a further improvement of the present invention, the following components are also included

[0011] Vitamin C 0.36 parts;

[0012] Vitamin D 0.00005 parts;

[0013] Vitamin B6 0.002 parts;

[0014] Vitamin B12 0.0000024 parts.

[0015] As a further improvement of the present invention, the following components are also included

[0016] 0.09 parts of magnesium;

[0017] Zinc 0.023 parts.

[0018] The beneficial effects of the present invention are:

[0019] 1. It takes effect quickly and is effective in improving sleep disorders;

[0020] 2. Compared with other insomnia treatment products on the market, the raw materials of the formula are convenient and easy to obtain;

[0021] 3. As a type of food formula, it mainly refers to GB 14880-2012, which can be safe and without side effects.

[0022] 4. It can be used as an auxiliary therapeutic food for insomniacs or high-risk groups to improve or prevent sleep disorders and a series of problems caused by them. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] Figure 1 Establish a flow chart for the animal model of the present invention;

[0024] Figure 2 It is an attack time comparison diagram of the present invention;

[0025] Figure 3 This is a comparison chart of serum corticosterone (CORT) concentrations of the HPA axis in mice of the present invention;

[0026] Figure 4 This is a graph of CRH levels in each group of mice of the present invention;

[0027] Figure 5 Graph showing ACTH levels in each group of mice of the present invention. DETAILED DESCRIPTION

[0028] The present invention will be further described below in detail with reference to the embodiments shown in the accompanying drawings.

[0029] The complex nutritional formula of this program consists of four parts: food and medicine, vitamins, minerals and raw milk (the percentages are 7100mg: 3.6~3.7mg: 1.1~1.2mg / 200mL raw milk).

[0030] Among them, the food and medicine ingredients include: 50g sour cherry, 10g wild jujube kernel, 5g apigenin, and 6g lily.

[0031] Vitamins: Vitamin C 36mg, Vitamin D 5μg, Vitamin B6 0.2mg, Vitamin B12 0.24μg.

[0032] Among minerals: Contains 9 mg of magnesium and 2.3 mg of zinc.

[0033] Sleep disorders are the result of the combined effects of the central nervous system, melatonin, inflammatory factors and other factors. Among them, serotonin, as an important neurotransmitter, is not only involved in the maintenance and regulation of normal physiological states such as sleep, but also has a certain regulatory effect on mental and psychological diseases. Sour cherries are foods rich in tryptophan, melatonin and anthocyanins. Tryptophan is a precursor of serotonin and melatonin. Melatonin acts on the suprachiasmatic nucleus of the brain to stimulate sleep effects, and anthocyanins can inhibit inflammatory responses. The synergistic effect has a good sleep-inducing effect. In addition, Chinese medicinal materials such as sour jujube seeds, apigenin and lily can also inhibit inflammation and have a calming and soothing effect on sleep.

[0034] There are also some vitamins and minerals that have a synergistic effect on sour cherry sleep, thus achieving a better sleep-aiding effect. Among them, vitamin C can promote the synthesis of neurotransmitters. When the body lacks vitamin C, it will lead to poor sleep quality, insomnia, and dreaminess. There are also studies that show that sleep rhythm is related to vitamin D. The delay of the sleep period is accompanied by a lack of vitamin D in the diet. In people with sleep disorders, supplementing vitamin D can improve sleep quality and reduce sleep latency. Vitamin B6 and vitamin B12 are substances that can help regulate the nervous system. They can assist the brain in producing tryptophan and melatonin, promote the conversion of tryptophan to serotonin, make the mood happy and calm, and promote deep sleep. Zinc, as an essential trace element for the human body, plays a vital role in brain neurotransmitters, especially in the blue locus of the brain; zinc also participates in the metabolism of melatonin and promotes the production of melatonin; taking zinc can reduce cortisol in the body, increase GABA, achieve a calming effect, and thus promote sleep. Magnesium is the fourth largest mineral in the human body and is responsible for more than 300 biochemical reactions in the body. Magnesium can relieve muscle tension and increase gamma-aminobutyric acid (GABA) in the body, relieving nervous tension. Long-term physical or mental stress can deplete the body's magnesium, and magnesium deficiency can further aggravate the stress response.

[0035] In addition, milk contains nearly 100 ingredients needed by the human body, such as protein, calcium, and phosphorus, and its digestion and absorption rate can be as high as 98%. The tryptophan and melatonin contained in milk can help soothe nerves, calm the mind, and improve sleep quality. Studies have also found that a peptide mixture called casein trypsin hydrolyzate in milk can significantly prolong sleep time.

[0036] The compound nutritional formula of this program has the following effects:

[0037] 1. It takes effect quickly and is effective in improving sleep disorders;

[0038] 2. Compared with other insomnia treatment products on the market, the raw materials of the formula are convenient and easy to obtain;

[0039] 3. As a type of food formula, it mainly refers to GB 14880-2012, which is safe and has no side effects.

[0040] 4. It can be used as an auxiliary therapeutic food for insomniacs or high-risk groups to improve or prevent sleep disorders and a series of problems caused by them.

[0041] As a verification, this plan provides the following data for illustration:

[0042] 1. Animal Model Establishment

[0043] Reference Figure 1 As shown in the figure, CD-1 (ICR) adult male mice were first maintained in an adaptive feeding system for 7 days to ensure that the mice's sleep was not affected by the environment, and their eating and various behaviors were normal. Figure 1 As shown, the model was established on the 8th day, and the mice were injected with 165 mg / kg of para-chlorophenylalanine (PCPA) for 2 days. After the model was successfully established, the modeled insomnia mice were randomly divided into 4 groups and numbered, with 10 mice in each group. The blank control group was non-insomnia modeled mice, including blank control group, model group, low-dose compound formula group, high-dose compound formula group, and diazepam group. The 7-day intervention began with this. The model group and the blank control group were gavaged with pure milk, the low-dose compound formula group was gavaged with a low-dose compound formula for 7 consecutive days, the high-dose compound formula group was gavaged with a high-dose compound formula for 7 consecutive days, and the diazepam group was gavaged with 40 mg / kg diazepam solution for 7 consecutive days.

[0044] 2. Attack Experiment

[0045] Reference Figure 2 As shown, the attack time of the control group was 253.00 (237.75, 295.00) s; the attack time of the model group was 93.50 (90.50, 97.75) s; the attack time of the low-dose group was 135.50 (122.00, 147.75) s; the attack time of the high-dose group was 170.50 (152.75, 188.25) s; the attack time of the diazepam group was 208.00 (195.75, 217.50) s. Compared with the control group, the attack time of the model group was significantly reduced (P < 0.001), indicating that insomnia caused stress response in mice, resulting in obvious group rejection. The attack time of the high-dose group was longer than that of the model group, indicating that the high-dose complex has a certain effect in treating insomnia.

[0046] 3. Serum corticosterone (CORT) concentration measurement

[0047] Reference Figure 3As shown, the CORT concentration in the control group was (11.01±1.90) ng / L; the CORT concentration in the model group was (15.08±0.90) ng / L; the CORT concentration in the low-dose group was (10.12±1.30) ng / L; the CORT concentration in the high-dose group was (11.08±1.65) ng / L; and the CORT concentration in the diazepam group was (9.33±1.00) ng / L. One-way ANOVA showed that the overall difference was statistically significant (F=17.436, P<0.001). Compared with the control group, the CORT concentration in the model group increased significantly (P<0.001), indicating that insomnia caused an increase in CORT secretion in the HPA axis of mice, and the increase in inhibitory substances led to sleep disorders, and the model was successfully established; the CORT concentration in the low-dose group was lower than that in the model group, and there was a significant difference (P<0.001); compared with the CORT concentration in the model group, the high-dose group was significantly lower, with statistical significance (P<0.001). This shows that the compound formula can reduce the serum CORT of the HPA axis, thereby improving sleep quality and achieving a calming and sleep-promoting effect.

[0048] 4. Effects of Suanzaoren Sleep-Aiding Milk on HPA Axis-Related Hormones

[0049] In order to evaluate the secretion level of HPA axis-related hormones, we used ELISA kits to detect the levels of CRH and ACTH in serum. Figure 4 As shown in the figure, compared with the control group, the CRH content in the serum of the model group mice was significantly increased (P < 0.01); compared with the model group, the CRH content in the low-dose, high-dose and diazepam groups was significantly decreased (P < 0.01). Figure 5 As shown, compared with the control group, the ACTH content in the serum of the model group mice was significantly increased (P < 0.01); compared with the model group, the ACTH content in the low-dose, high-dose and diazepam groups were significantly decreased (P < 0.01). The results showed that Suanzaoren sleep-aiding milk can regulate the secretion of HPA axis-related hormones, thereby effectively improving the insomnia caused by HPA axis dysfunction. Figure 4 and Figure 5 , ΔP<0.05ΔΔP<0.01, compared with the control group; *P<0.05**P<0.01, compared with the model group.

[0050] The above is only a preferred embodiment of the present invention, and the protection scope of the present invention is not limited to the above embodiments. All technical solutions under the concept of the present invention belong to the protection scope of the present invention. It should be pointed out that for ordinary technicians in this technical field, some improvements and modifications without departing from the principle of the present invention should also be regarded as the protection scope of the present invention.

Claims

1. A composite nutritional formula for alleviating sleep disorders, characterized in that: The components include: 500 servings of sour cherry; 100 parts of spiny jujube seeds; Apigenin 50 parts; 60 servings of lily.

2. The composite nutritional formula for alleviating sleep disorders according to claim 1, characterized in that: It also includes the following components Vitamin C 0.36 parts; Vitamin D 0.00005 parts; Vitamin B6 0.002 parts; Vitamin B12 0.0000024 parts.

3. The composite nutritional formula for alleviating sleep disorders according to claim 1 or 2, characterized in that: It also includes the following components 0.09 parts of magnesium; Zinc 0.023 parts.